The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TOP NEWS SUMMARY: UK Signs Vaccine Supply Deal With Sanofi And GSK

Wed, 29th Jul 2020 11:33

(Alliance News) - The following is a summary of top news stories Wednesday.

----------

COMPANIES

----------

Sanofi and GlaxoSmithKline have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a Covid-19 vaccine. The vaccine candidate - developed by Paris-based pharmaceutical company Sanofi in partnership with Brentford, England-based drugmaker GSK - is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK's pandemic adjuvant technology. Roger Connor, president of GSK Vaccines, said: "We believe that this adjuvanted vaccine candidate has the potential to play a significant role in overcoming the Covid-19 pandemic, both in the UK and around the world." Sanofi said it is leading the clinical development and registration of the Covid-19 vaccine and expects a phase 1/2 study to start in September, followed by a phase 3 study by the end of 2020. If the data are positive, regulatory approval could be achieved by the first half of 2021.

----------

Barclays reported a sharp drop in interim profit, as the lender was forced to up its credit impairment charges dramatically to deal the fallout of the Covid-19 pandemic. For the six months to June 30, Barclays pretax profit dropped 58% year on year to GBP1.27 billion from GBP3.01 billion. Total income improved 8% to GBP11.62 billion from GBP10.79 billion, but Barclays was forced to up its credit impairment charges to GBP3.74 billion from GBP928 million the year before. Barclays said the provision increase was largely due to "revised IFRS 9 scenarios" driven by Covid-19. The scenarios reflect "forecast deterioration in macroeconomic variables including a prolonged period of heightened UK and US unemployment, partially offset by the estimated impact of central bank, government and other support measures". As a result, net operating income sunk 20% to GBP7.88 billion from GBP9.86 billion.

----------

Next announced its second-quarter sales were "much better than expected" but still a far cry from last year's second quarter results. The FTSE 100-listed clothing retailer said its online warehouse picking and dispatch capacity returned to normal levels quicker than expected and UK and Ireland stores are now open for business. As a result, full price sales including interest income for the second quarter ended July 25 were were "significantly" ahead of expectations, down 28% compared to the year prior. Online sales were up 9%, while retail store sales were down 32% on a like-for-like basis. In the first half as a whole, sales were down 33% on a year before, with online sales down 11% and retail store sales down 62%. Next has modelled three new scenarios based on full price sales for the full year being down 18%, 26% and 33%. The company said the middle scenario is what is expected at this time assuming sales are down 19% in the second half. Next expects full year pretax profit to be GBP195 million, following the central scenario. This is a stark contrast to the GBP734 million expected in pretax profit in January earlier this year and the GBP748.5 million recorded in financial 2020.

----------

Anglo-Australian miner Rio Tinto said it put in a "resilient" performance in the first half of 2020 with revenue down marginally, and it increased its interim dividend. The FTSE 100 mining group with operations in 36 countries recorded a small drop in its revenue for the first six months to June 30 which was at USD19.36 billion, 6.6% from USD20.72 billion a year before. This was mainly due to lower prices and volumes for copper and lower aluminium prices, the company said. Pretax profit was up 1.7% at USD5.28 billion compared to last year's first half of USD5.19 billion. Rio Tinto's underlying earnings before interest, tax, depreciation and amortisation was down 5.6% at USD9.64 billion, from USD10.25 billion the year prior. Despite the marginal drop in revenue, Rio Tinto announced an interim dividend of 155 US cents per share, costing USD2.5 billion, and up 2.6% from last year's interim dividend of 151 US cents per share.

----------

MARKETS

----------

European stock markets "continued their consolidation on Wednesday, following an Asian trading session without clear direction", said Pierre Veyret, technical analyst at ActivTrades. "The current lack of market directionality is of course related to some profit taking moves but that's not the only factor. Between today's Fed statement, the recent resurgence of the coronavirus, national data and corporate earnings, market operators have a lot to digest this week," he said. The US Federal Reserve releases its latest policy decision at 1900 BST, and ahead of the central bank's announcement the dollar was softer. Wall Street was called for a higher, albeit cautious, start, with the Dow Jones seen teetering into the green and the S&P 500 up 0.1%, while the Nasdaq is set to rise 0.4%.

----------

FTSE 100: up 0.3% at 6,147.57

FTSE 250: down 0.3% at 17,235.66

AIM ALL-SHARE: up 0.1% at 892.24

GBP: higher at USD1.2968 (USD1.2930)

EUR: higher at USD1.1745 (USD1.1731)

GOLD: firm at USD1,955.73 per ounce (USD1,953.15)

OIL (Brent): higher at USD43.81 a barrel (USD43.09)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Heathrow has urged the UK government to stop imposing "quarantine roulette" on travellers as it announced a pretax loss of GBP1.1 billion in the first six months of the year. Chief Executive John Holland-Kaye said the financial results "should serve as a clarion call" to ministers to introduce a scheme for coronavirus testing of arriving passengers. He wants the 14-day self-isolation requirement to be eased for people arriving from countries not on the government's exemption list if they test negative for the virus. It comes after UK Prime Minister Boris Johnson warned that further European nations could lose their exempted status amid signs of a "second wave" of Covid-19. Johnson triggered a diplomatic row with Spain by reimposing a warning against all but essential travel to the country and insisting that travellers arriving in the UK from there spend 14 days in quarantine. Heathrow's passenger numbers were down 96% year on year between April and June. It posted a pretax loss of GBP1.1 billion in the first six months of 2020, down from a GBP7 million profit in the same period a year ago. This came on revenue of GBP712 million, around half of 2019's levels.

----------

China reported 101 new coronavirus cases, its highest single-day figure in three months, as gyms, bars and museums closed in infection hotspots. Of the new cases, 98 were domestic infections, mostly in the northwestern region of Xinjiang, where a growing cluster first discovered earlier this month has prompted mass testing and restrictions. China – where the global outbreak first emerged – had largely brought domestic transmission under control through targeted lockdowns, travel restrictions and testing. But sporadic regional outbreaks have illustrated the difficulty of keeping the virus at bay. The last time it recorded so many new cases was April 13, when 108 infections were confirmed – mostly imported. Authorities have concentrated their attention on a cluster which emerged last week at a food processing plant in Dalian, in the northeastern province of Liaoning. Officials said workers there handled contaminated packaging of imported seafood.

----------

Democrats and Republicans in the US Congress were far from reaching an agreement on a new package to support the world's leading economy, brought to its knees by the virus pandemic. "Very sadly, after months of deadly delay, the Republicans have unveiled a proposal that would only prolong the suffering for millions of workers and families across America," House Speaker Nancy Pelosi wrote in letter to her fellow Democrats, following two rounds of negotiations with the White House and Republican lawmakers. In the Senate, Republican majority leader Mitch McConnell defended his party's proposal, unveiled on Monday, that calls for USD1 trillion in stimulus aid. Back in May, the House Democrats unveiled a USD3 trillion coronavirus response package, the largest yet, to fund efforts to fight the pandemic and provide emergency payments to millions of Americans. With only 100 days to go before the US presidential election, talks are tense between the parties – but also among Republicans, some of whom are refusing to spend much and are even criticizing the White House.

----------

With speculation rife on who will be Joe Biden's running mate in the November US presidential election, the Democratic presumptive nominee said he would make a choice next week. "I'm going to have a choice in the first week of August and I promise I'll let you know when I do," Biden said during a campaign event on Tuesday. Biden, himself a former vice president to Barack Obama, pledged during the Democratic primary he will select a woman as his running mate. There are a number of people the campaign has been vetting to run as vice president alongside Biden, including Kamala Harris and Elizabeth Warren, both sitting senators who ran against him in the primary. Tammy Duckworth, another senator and a war veteran, is also on the list. Also high up in the vetting process is Susan Rice, a former national security adviser and ambassador to the UN under Obama. There are a number of congresswomen also being considered, along with governors and a mayor.

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.